Hua Medicine
HKEX:2552
Hua Medicine
Cash from Operating Activities
Hua Medicine
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
H
|
Hua Medicine
HKEX:2552
|
Cash from Operating Activities
-¥230.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Cash from Operating Activities
¥2.7B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Cash from Operating Activities
¥3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
108%
|
CAGR 10-Years
30%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Cash from Operating Activities
¥3.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Cash from Operating Activities
¥3.5B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
18%
|
CAGR 10-Years
26%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Cash from Operating Activities
¥927.2m
|
CAGR 3-Years
38%
|
CAGR 5-Years
42%
|
CAGR 10-Years
N/A
|
See Also
What is Hua Medicine's Cash from Operating Activities?
Cash from Operating Activities
-230.1m
CNY
Based on the financial report for Dec 31, 2022, Hua Medicine's Cash from Operating Activities amounts to -230.1m CNY.
What is Hua Medicine's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-3%
Over the last year, the Cash from Operating Activities growth was 16%. The average annual Cash from Operating Activities growth rates for Hua Medicine have been 12% over the past three years , -3% over the past five years .